The Efficacy and Safety of PEG-rhG-CSF in Neutropenia After Chemotherapy
Clinical trial NCT02905916 · UNKNOWN
Trial details
- NCT number
- NCT02905916
- Sponsor
- Peking University
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2018-06-01
- Enrollment
- 217
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.